360 related articles for article (PubMed ID: 17270227)
21. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
22. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R
Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526
[TBL] [Abstract][Full Text] [Related]
24. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging].
Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F
Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370
[TBL] [Abstract][Full Text] [Related]
25. Investigations of the metabolites of the trypanocidal drug melarsoprol.
Keiser J; Ericsson O; Burri C
Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
[TBL] [Abstract][Full Text] [Related]
27. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
[TBL] [Abstract][Full Text] [Related]
28. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.
Kumar N; Orenstein R; Uslan DZ; Berbari EF; Klein CJ; Windebank AJ
Neurology; 2006 Apr; 66(7):1120-1. PubMed ID: 16540605
[No Abstract] [Full Text] [Related]
29. [Complications observed in the treatment of trypanosomiasis in the Congo].
Ginoux PY; Bissadidi N; Frezil JL
Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
[TBL] [Abstract][Full Text] [Related]
30. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
Chappuis F
Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
[No Abstract] [Full Text] [Related]
31. Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model.
Rashid K; Wachira FN; Nyariki JN; Isaac AO
Parasitol Int; 2014 Apr; 63(2):417-26. PubMed ID: 24440762
[TBL] [Abstract][Full Text] [Related]
32. Randomized, controlled trial of treatments for second-stage sleeping sickness.
Woodrow CJ; Abel PM; Krishna S
J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
[No Abstract] [Full Text] [Related]
33. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
Maina N; Maina KJ; Mäser P; Brun R
Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
[TBL] [Abstract][Full Text] [Related]
34. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
Robays J; Raguenaud ME; Josenando T; Boelaert M
Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
[TBL] [Abstract][Full Text] [Related]
35. Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up.
Truc P; Jamonneau V; Cuny G; Frézil JL
Bull World Health Organ; 1999; 77(9):745-8. PubMed ID: 10534898
[TBL] [Abstract][Full Text] [Related]
36. Eflornithine for the treatment of human African trypanosomiasis.
Burri C; Brun R
Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
38. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Miezan TW; Dje NN; Doua F; Boa F
Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.
Kuepfer I; Schmid C; Allan M; Edielu A; Haary EP; Kakembo A; Kibona S; Blum J; Burri C
PLoS Negl Trop Dis; 2012 Aug; 6(8):e1695. PubMed ID: 22970329
[TBL] [Abstract][Full Text] [Related]
40. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
Veeken HJ; Ebeling MC; Dolmans WM
Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
